

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.36522738 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.36522738 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.85906651 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.85906651 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.42390739 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.74328138 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.74095785 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62711176 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.59598129 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.59598129 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.59598129 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.37931012 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.35949052 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.23285976 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.12339327 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.03879317 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03129201 |
| 18 | protein carboxylation (GO:0018214) | 5.03129201 |
| 19 | urea metabolic process (GO:0019627) | 5.01734604 |
| 20 | urea cycle (GO:0000050) | 5.01734604 |
| 21 | cysteine metabolic process (GO:0006534) | 4.96445336 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.94547449 |
| 23 | bile acid metabolic process (GO:0008206) | 4.91635924 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.90504535 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.86118336 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.76965849 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.61057964 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.58099115 |
| 29 | tyrosine metabolic process (GO:0006570) | 4.56732100 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 4.56498443 |
| 31 | coenzyme catabolic process (GO:0009109) | 4.50114294 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.45794807 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.45717219 |
| 34 | regulation of complement activation (GO:0030449) | 4.44816443 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.40229726 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.40229726 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.40229726 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.37801381 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.35951570 |
| 40 | cellular glucuronidation (GO:0052695) | 4.33523244 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 4.33317024 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.33177591 |
| 43 | fatty acid elongation (GO:0030497) | 4.31259962 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.29263271 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.29263271 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.26236263 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.15869724 |
| 48 | * sterol biosynthetic process (GO:0016126) | 4.15272891 |
| 49 | phospholipid efflux (GO:0033700) | 4.12917968 |
| 50 | bile acid and bile salt transport (GO:0015721) | 4.12372283 |
| 51 | cholesterol efflux (GO:0033344) | 4.12317858 |
| 52 | cellular biogenic amine catabolic process (GO:0042402) | 4.08838499 |
| 53 | amine catabolic process (GO:0009310) | 4.08838499 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.06778130 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.06778130 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.06043269 |
| 57 | ethanol oxidation (GO:0006069) | 4.05010579 |
| 58 | aldehyde catabolic process (GO:0046185) | 4.03315294 |
| 59 | acetyl-CoA metabolic process (GO:0006084) | 4.00431331 |
| 60 | cofactor catabolic process (GO:0051187) | 3.99986010 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 3.97429496 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.94045417 |
| 63 | uronic acid metabolic process (GO:0006063) | 3.93618033 |
| 64 | glucuronate metabolic process (GO:0019585) | 3.93618033 |
| 65 | glutamate metabolic process (GO:0006536) | 3.92311131 |
| 66 | very long-chain fatty acid metabolic process (GO:0000038) | 3.91837049 |
| 67 | lysine catabolic process (GO:0006554) | 3.88696285 |
| 68 | lysine metabolic process (GO:0006553) | 3.88696285 |
| 69 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.85813541 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85772468 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 3.85035533 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 3.81461557 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.79404637 |
| 74 | fibrinolysis (GO:0042730) | 3.78207770 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.76022806 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.75240636 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.74275430 |
| 78 | * cholesterol biosynthetic process (GO:0006695) | 3.72285613 |
| 79 | glycine metabolic process (GO:0006544) | 3.66935199 |
| 80 | arginine metabolic process (GO:0006525) | 3.64504527 |
| 81 | cholesterol homeostasis (GO:0042632) | 3.63187727 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.62835967 |
| 83 | ketone body metabolic process (GO:1902224) | 3.61146497 |
| 84 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59708984 |
| 85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59708984 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59407521 |
| 87 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.59292369 |
| 88 | drug catabolic process (GO:0042737) | 3.59166805 |
| 89 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.57084262 |
| 90 | sterol homeostasis (GO:0055092) | 3.56866678 |
| 91 | regulation of cholesterol metabolic process (GO:0090181) | 3.55099443 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.54758455 |
| 93 | L-serine metabolic process (GO:0006563) | 3.54300553 |
| 94 | opsonization (GO:0008228) | 3.49709951 |
| 95 | DNA double-strand break processing (GO:0000729) | 3.49388941 |
| 96 | heme transport (GO:0015886) | 3.49380979 |
| 97 | negative regulation of lipase activity (GO:0060192) | 3.49305097 |
| 98 | organic acid catabolic process (GO:0016054) | 3.49287464 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.49287464 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.48581975 |
| 101 | intestinal cholesterol absorption (GO:0030299) | 3.45244789 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.42721940 |
| 103 | protein-lipid complex assembly (GO:0065005) | 3.42449116 |
| 104 | presynaptic membrane assembly (GO:0097105) | 3.27833264 |
| 105 | isoprenoid biosynthetic process (GO:0008299) | 3.21787881 |
| 106 | establishment of integrated proviral latency (GO:0075713) | 2.97802940 |
| 107 | chromatin remodeling at centromere (GO:0031055) | 2.94192413 |
| 108 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.93472605 |
| 109 | CENP-A containing nucleosome assembly (GO:0034080) | 2.82492407 |
| 110 | cullin deneddylation (GO:0010388) | 2.81548234 |
| 111 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.79435204 |
| 112 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.78995268 |
| 113 | anterior/posterior axis specification, embryo (GO:0008595) | 2.77487094 |
| 114 | presynaptic membrane organization (GO:0097090) | 2.74766898 |
| 115 | regulation of coenzyme metabolic process (GO:0051196) | 2.61143714 |
| 116 | regulation of cofactor metabolic process (GO:0051193) | 2.61143714 |
| 117 | protein neddylation (GO:0045116) | 2.58894725 |
| 118 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.58744232 |
| 119 | branched-chain amino acid catabolic process (GO:0009083) | 2.57237672 |
| 120 | regulation of glucokinase activity (GO:0033131) | 2.57174767 |
| 121 | regulation of hexokinase activity (GO:1903299) | 2.57174767 |
| 122 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.55497623 |
| 123 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.53965377 |
| 124 | proteasome assembly (GO:0043248) | 2.53476911 |
| 125 | histone exchange (GO:0043486) | 2.52514273 |
| 126 | protein deneddylation (GO:0000338) | 2.51935780 |
| 127 | response to nitrosative stress (GO:0051409) | 2.51786565 |
| 128 | negative regulation of DNA recombination (GO:0045910) | 2.49968486 |
| 129 | regulation of cardioblast differentiation (GO:0051890) | 2.47689100 |
| 130 | regulation of sulfur metabolic process (GO:0042762) | 2.45926057 |
| 131 | female gonad development (GO:0008585) | 2.44871073 |
| 132 | non-recombinational repair (GO:0000726) | 2.44331782 |
| 133 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.44331782 |
| 134 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.42089521 |
| 135 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.40887584 |
| 136 | regulation of centriole replication (GO:0046599) | 2.39678203 |
| 137 | DNA ligation (GO:0006266) | 2.39416287 |
| 138 | dorsal/ventral axis specification (GO:0009950) | 2.38701214 |
| 139 | paraxial mesoderm development (GO:0048339) | 2.38451901 |
| 140 | DNA damage response, detection of DNA damage (GO:0042769) | 2.36803629 |
| 141 | exogenous drug catabolic process (GO:0042738) | 2.35601318 |
| 142 | ribosome assembly (GO:0042255) | 2.35200737 |
| 143 | purine nucleobase biosynthetic process (GO:0009113) | 2.33444336 |
| 144 | L-methionine salvage (GO:0071267) | 2.32748647 |
| 145 | L-methionine biosynthetic process (GO:0071265) | 2.32748647 |
| 146 | amino acid salvage (GO:0043102) | 2.32748647 |
| 147 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.31817964 |
| 148 | DNA replication-independent nucleosome organization (GO:0034724) | 2.31817964 |
| 149 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.29165465 |
| 150 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.29165465 |
| 151 | spindle checkpoint (GO:0031577) | 2.28859053 |
| 152 | negative regulation of hormone metabolic process (GO:0032351) | 2.25497326 |
| 153 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.24465537 |
| 154 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.24465537 |
| 155 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.24465537 |
| 156 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.24465537 |
| 157 | negative regulation of sister chromatid segregation (GO:0033046) | 2.24465537 |
| 158 | mitotic spindle checkpoint (GO:0071174) | 2.24313275 |
| 159 | regulation of helicase activity (GO:0051095) | 2.22856943 |
| 160 | protein localization to kinetochore (GO:0034501) | 2.22712425 |
| 161 | C4-dicarboxylate transport (GO:0015740) | 2.18949870 |
| 162 | omega-hydroxylase P450 pathway (GO:0097267) | 2.18468338 |
| 163 | gap junction assembly (GO:0016264) | 2.17682387 |
| 164 | * steroid biosynthetic process (GO:0006694) | 2.17521157 |
| 165 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.16043956 |
| 166 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.16043956 |
| 167 | replication fork processing (GO:0031297) | 2.15607813 |
| 168 | negative regulation of chromosome segregation (GO:0051985) | 2.15433115 |
| 169 | anterior/posterior axis specification (GO:0009948) | 2.15351984 |
| 170 | lactate metabolic process (GO:0006089) | 2.11798432 |
| 171 | response to phenylpropanoid (GO:0080184) | 2.11520043 |
| 172 | vascular smooth muscle contraction (GO:0014829) | 2.11224571 |
| 173 | mitotic metaphase plate congression (GO:0007080) | 2.09851098 |
| 174 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.08653491 |
| 175 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.08653491 |
| 176 | metaphase plate congression (GO:0051310) | 2.08308583 |
| 177 | mitotic G2/M transition checkpoint (GO:0044818) | 2.08229179 |
| 178 | establishment of viral latency (GO:0019043) | 2.07458155 |
| 179 | IMP biosynthetic process (GO:0006188) | 2.07258777 |
| 180 | vitamin biosynthetic process (GO:0009110) | 2.06934082 |
| 181 | embryonic foregut morphogenesis (GO:0048617) | 2.06639142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.36946868 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.40835337 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.16952207 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.86926672 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.72061338 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.52752895 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.25072009 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.62906857 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.57909647 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.13058071 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.63819137 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.63207223 |
| 13 | FUS_26573619_Chip-Seq_HEK293_Human | 2.27019278 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.23673987 |
| 15 | EWS_26573619_Chip-Seq_HEK293_Human | 2.16353602 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.07177076 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.05897313 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.04663150 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4836742 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 1.97200169 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96249306 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.90666072 |
| 23 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.88964001 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86092080 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.84637043 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.81152362 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.80628826 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76625856 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67421873 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67110752 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66927931 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.61721360 |
| 33 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60758914 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60370126 |
| 35 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60336729 |
| 36 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.60244086 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.58658952 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.58203750 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57411599 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56951098 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53270505 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52157792 |
| 43 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.51499848 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.51298722 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.49271210 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.47439217 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47362456 |
| 48 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.44957503 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43891455 |
| 50 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.39451804 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38356599 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.38082382 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34413804 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33048231 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32492550 |
| 56 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31775222 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31137748 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31137748 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.28231667 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21894606 |
| 61 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21488052 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20885821 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20078035 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.20064699 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19090607 |
| 66 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18794829 |
| 67 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18251270 |
| 68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.17363360 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16419977 |
| 70 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.15846087 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15739469 |
| 72 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14187024 |
| 73 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.08880619 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08785248 |
| 75 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08443288 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04899505 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01870292 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01604919 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01600504 |
| 80 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01102477 |
| 81 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01102477 |
| 82 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00940346 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00359610 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99344018 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98896349 |
| 86 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98842476 |
| 87 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98598473 |
| 88 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98581174 |
| 89 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98313550 |
| 90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98000193 |
| 91 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97634067 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97093209 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96379032 |
| 94 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96227445 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.96080454 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95955675 |
| 97 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95654723 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95020136 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94681815 |
| 100 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94358220 |
| 101 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.94297556 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94282739 |
| 103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93018899 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92134038 |
| 105 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91673076 |
| 106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.91062998 |
| 107 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91002357 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84786233 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84520306 |
| 110 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84519800 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83270413 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81210712 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.80771766 |
| 114 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78667574 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77684932 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76926657 |
| 117 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.72302532 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72155297 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.71837443 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71182674 |
| 121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70254305 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69712347 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69330485 |
| 124 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.69172988 |
| 125 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68810715 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68582511 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.67881627 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67467254 |
| 129 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67238357 |
| 130 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.66907718 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.66605051 |
| 132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.64363654 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63462842 |
| 134 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.61468661 |
| 135 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.61203790 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.60849284 |
| 137 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60297213 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59968768 |
| 139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.59872665 |
| 140 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.59403336 |
| 141 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.59057666 |
| 142 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.58952099 |
| 143 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.58786387 |
| 144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58636861 |
| 145 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.57942198 |
| 146 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57584544 |
| 147 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.57331397 |
| 148 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56251685 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55532920 |
| 150 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54065318 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.53831321 |
| 152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.53215329 |
| 153 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.53124447 |
| 154 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.52842144 |
| 155 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.52842144 |
| 156 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.52501985 |
| 157 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.51942118 |
| 158 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51905003 |
| 159 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.51840212 |
| 160 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.51471529 |
| 161 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.51454643 |
| 162 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50190534 |
| 163 | P300_19829295_ChIP-Seq_ESCs_Human | 0.49818715 |
| 164 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.49622087 |
| 165 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49330470 |
| 166 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.49324720 |
| 167 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.48814724 |
| 168 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.48331529 |
| 169 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.48322356 |
| 170 | NCOR_22424771_ChIP-Seq_293T_Human | 0.47856387 |
| 171 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.47706586 |
| 172 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.46307752 |
| 173 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46295150 |
| 174 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.45796326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15065988 |
| 2 | MP0005360_urolithiasis | 7.20502361 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.20784278 |
| 4 | MP0005365_abnormal_bile_salt | 5.78250863 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93477903 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.50520798 |
| 7 | MP0003941_abnormal_skin_development | 4.06936583 |
| 8 | MP0003252_abnormal_bile_duct | 3.57769941 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.39838116 |
| 10 | MP0009840_abnormal_foam_cell | 3.24416628 |
| 11 | MP0005083_abnormal_biliary_tract | 3.23389402 |
| 12 | MP0003195_calcinosis | 3.01031723 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.96844607 |
| 14 | MP0002102_abnormal_ear_morphology | 2.64987278 |
| 15 | MP0005332_abnormal_amino_acid | 2.63352785 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.53123070 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.15891449 |
| 18 | MP0001529_abnormal_vocalization | 2.11783389 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.99791108 |
| 20 | MP0000609_abnormal_liver_physiology | 1.96820517 |
| 21 | MP0003567_abnormal_fetal_cardiomyocyte | 1.93933078 |
| 22 | MP0003122_maternal_imprinting | 1.93652228 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.91468488 |
| 24 | MP0003868_abnormal_feces_composition | 1.86583414 |
| 25 | * MP0003937_abnormal_limbs/digits/tail_de | 1.82375914 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.78930154 |
| 27 | MP0005451_abnormal_body_composition | 1.71616744 |
| 28 | MP0001984_abnormal_olfaction | 1.70720836 |
| 29 | MP0009697_abnormal_copulation | 1.66191498 |
| 30 | MP0003121_genomic_imprinting | 1.63954069 |
| 31 | MP0006054_spinal_hemorrhage | 1.63228136 |
| 32 | MP0003011_delayed_dark_adaptation | 1.63048821 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.62284403 |
| 34 | MP0001764_abnormal_homeostasis | 1.60377939 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.60316378 |
| 36 | MP0001293_anophthalmia | 1.59745828 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59508279 |
| 38 | MP0003119_abnormal_digestive_system | 1.58273079 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.54360077 |
| 40 | MP0003136_yellow_coat_color | 1.48766105 |
| 41 | MP0003186_abnormal_redox_activity | 1.44669157 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.42641153 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.42013932 |
| 44 | MP0008058_abnormal_DNA_repair | 1.41779780 |
| 45 | MP0000604_amyloidosis | 1.41249170 |
| 46 | MP0002697_abnormal_eye_size | 1.37236198 |
| 47 | MP0003690_abnormal_glial_cell | 1.36494851 |
| 48 | MP0000516_abnormal_urinary_system | 1.35100153 |
| 49 | MP0005367_renal/urinary_system_phenotyp | 1.35100153 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.32671156 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.32248858 |
| 52 | MP0004133_heterotaxia | 1.32036697 |
| 53 | MP0002938_white_spotting | 1.31931191 |
| 54 | MP0005187_abnormal_penis_morphology | 1.31610579 |
| 55 | MP0008932_abnormal_embryonic_tissue | 1.31341710 |
| 56 | * MP0002233_abnormal_nose_morphology | 1.29229533 |
| 57 | MP0001188_hyperpigmentation | 1.26716268 |
| 58 | MP0003123_paternal_imprinting | 1.24567690 |
| 59 | MP0003329_amyloid_beta_deposits | 1.23073499 |
| 60 | MP0002736_abnormal_nociception_after | 1.22724037 |
| 61 | * MP0001177_atelectasis | 1.22610028 |
| 62 | MP0004272_abnormal_basement_membrane | 1.20533826 |
| 63 | MP0004270_analgesia | 1.20360947 |
| 64 | MP0000462_abnormal_digestive_system | 1.17696052 |
| 65 | MP0005408_hypopigmentation | 1.17579598 |
| 66 | MP0005647_abnormal_sex_gland | 1.12712021 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.12280391 |
| 68 | MP0003693_abnormal_embryo_hatching | 1.11491776 |
| 69 | MP0003880_abnormal_central_pattern | 1.11406652 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 1.10874725 |
| 71 | MP0001286_abnormal_eye_development | 1.09292814 |
| 72 | MP0002084_abnormal_developmental_patter | 1.08954382 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.07400642 |
| 74 | MP0005253_abnormal_eye_physiology | 1.05552210 |
| 75 | MP0003385_abnormal_body_wall | 1.04375039 |
| 76 | MP0008789_abnormal_olfactory_epithelium | 1.03816526 |
| 77 | MP0009764_decreased_sensitivity_to | 1.01944255 |
| 78 | MP0000920_abnormal_myelination | 1.01166690 |
| 79 | MP0003283_abnormal_digestive_organ | 1.00791919 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 0.99814710 |
| 81 | MP0005380_embryogenesis_phenotype | 0.99814710 |
| 82 | * MP0000598_abnormal_liver_morphology | 0.97566067 |
| 83 | MP0000778_abnormal_nervous_system | 0.97542927 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 0.96020921 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.95081614 |
| 86 | MP0005499_abnormal_olfactory_system | 0.95081614 |
| 87 | MP0002254_reproductive_system_inflammat | 0.94763364 |
| 88 | * MP0009672_abnormal_birth_weight | 0.94707530 |
| 89 | MP0009763_increased_sensitivity_to | 0.93841569 |
| 90 | MP0003984_embryonic_growth_retardation | 0.93399553 |
| 91 | MP0002088_abnormal_embryonic_growth/wei | 0.93357399 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.93094406 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.91535726 |
| 94 | MP0003111_abnormal_nucleus_morphology | 0.90955029 |
| 95 | MP0008057_abnormal_DNA_replication | 0.90852561 |
| 96 | MP0004084_abnormal_cardiac_muscle | 0.87172773 |
| 97 | * MP0009703_decreased_birth_body | 0.86936834 |
| 98 | * MP0003755_abnormal_palate_morphology | 0.85499962 |
| 99 | MP0003787_abnormal_imprinting | 0.85089964 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.84264020 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.83267052 |
| 102 | MP0001661_extended_life_span | 0.83111263 |
| 103 | MP0008469_abnormal_protein_level | 0.82762950 |
| 104 | MP0002085_abnormal_embryonic_tissue | 0.82335725 |
| 105 | * MP0002111_abnormal_tail_morphology | 0.82078064 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.81882316 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.79559923 |
| 108 | MP0008775_abnormal_heart_ventricle | 0.79476847 |
| 109 | MP0006292_abnormal_olfactory_placode | 0.79437067 |
| 110 | MP0001697_abnormal_embryo_size | 0.78527065 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.78360410 |
| 112 | MP0001730_embryonic_growth_arrest | 0.78253925 |
| 113 | MP0000537_abnormal_urethra_morphology | 0.78119602 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.76996169 |
| 115 | MP0004381_abnormal_hair_follicle | 0.76526217 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.74492348 |
| 117 | MP0005391_vision/eye_phenotype | 0.74152876 |
| 118 | MP0005084_abnormal_gallbladder_morpholo | 0.74140579 |
| 119 | MP0001486_abnormal_startle_reflex | 0.73796530 |
| 120 | * MP0004197_abnormal_fetal_growth/weight/ | 0.73208029 |
| 121 | MP0003935_abnormal_craniofacial_develop | 0.73114438 |
| 122 | MP0003077_abnormal_cell_cycle | 0.72447781 |
| 123 | MP0002734_abnormal_mechanical_nocicepti | 0.71121287 |
| 124 | MP0003861_abnormal_nervous_system | 0.70017535 |
| 125 | MP0002127_abnormal_cardiovascular_syste | 0.69950581 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.69412530 |
| 127 | MP0005334_abnormal_fat_pad | 0.68478989 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.68334139 |
| 129 | MP0005535_abnormal_body_temperature | 0.68148255 |
| 130 | MP0006036_abnormal_mitochondrial_physio | 0.67422329 |
| 131 | MP0003705_abnormal_hypodermis_morpholog | 0.65701594 |
| 132 | MP0004130_abnormal_muscle_cell | 0.64086809 |
| 133 | MP0005670_abnormal_white_adipose | 0.62852232 |
| 134 | * MP0002078_abnormal_glucose_homeostasis | 0.62475801 |
| 135 | MP0009384_cardiac_valve_regurgitation | 0.60241280 |
| 136 | MP0003718_maternal_effect | 0.57987389 |
| 137 | MP0010368_abnormal_lymphatic_system | 0.57122077 |
| 138 | MP0003724_increased_susceptibility_to | 0.56815549 |
| 139 | MP0006082_CNS_inflammation | 0.56064654 |
| 140 | MP0003075_altered_response_to | 0.54664209 |
| 141 | MP0005448_abnormal_energy_balance | 0.54199752 |
| 142 | MP0005266_abnormal_metabolism | 0.53621429 |
| 143 | * MP0002971_abnormal_brown_adipose | 0.51181410 |
| 144 | MP0005395_other_phenotype | 0.50695284 |
| 145 | MP0002822_catalepsy | 0.50306379 |
| 146 | MP0002796_impaired_skin_barrier | 0.48906028 |
| 147 | MP0002090_abnormal_vision | 0.46681226 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.45807717 |
| 149 | MP0000579_abnormal_nail_morphology | 0.45669573 |
| 150 | MP0003632_abnormal_nervous_system | 0.45180151 |
| 151 | MP0001243_abnormal_dermal_layer | 0.44981444 |
| 152 | MP0005164_abnormal_response_to | 0.44271816 |
| 153 | MP0006035_abnormal_mitochondrial_morpho | 0.44031700 |
| 154 | MP0005464_abnormal_platelet_physiology | 0.43717335 |
| 155 | MP0008874_decreased_physiological_sensi | 0.43655734 |
| 156 | MP0001756_abnormal_urination | 0.43320653 |
| 157 | MP0005058_abnormal_lysosome_morphology | 0.42656311 |
| 158 | MP0004782_abnormal_surfactant_physiolog | 0.42443729 |
| 159 | MP0004142_abnormal_muscle_tone | 0.42125522 |
| 160 | MP0005166_decreased_susceptibility_to | 0.41645074 |
| 161 | MP0008873_increased_physiological_sensi | 0.41281921 |
| 162 | MP0002295_abnormal_pulmonary_circulatio | 0.39749237 |
| 163 | MP0009053_abnormal_anal_canal | 0.39102658 |
| 164 | MP0000647_abnormal_sebaceous_gland | 0.39038773 |
| 165 | MP0000427_abnormal_hair_cycle | 0.38402737 |
| 166 | MP0000230_abnormal_systemic_arterial | 0.37195900 |
| 167 | MP0003638_abnormal_response/metabolism_ | 0.35629725 |
| 168 | MP0002132_abnormal_respiratory_system | 0.35028128 |
| 169 | MP0004883_abnormal_blood_vessel | 0.34813270 |
| 170 | MP0003950_abnormal_plasma_membrane | 0.34740984 |
| 171 | MP0002060_abnormal_skin_morphology | 0.34514624 |
| 172 | MP0003953_abnormal_hormone_level | 0.34432920 |
| 173 | MP0003436_decreased_susceptibility_to | 0.34039087 |
| 174 | MP0000566_synostosis | 0.34015191 |
| 175 | MP0002136_abnormal_kidney_physiology | 0.33809265 |
| 176 | * MP0005220_abnormal_exocrine_pancreas | 0.32907156 |
| 177 | MP0005248_abnormal_Harderian_gland | 0.32484296 |
| 178 | MP0003631_nervous_system_phenotype | 0.31956920 |
| 179 | MP0003633_abnormal_nervous_system | 0.30107901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.09718689 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.02876387 |
| 3 | * Intrahepatic cholestasis (HP:0001406) | 6.89903635 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.32365374 |
| 5 | Xanthomatosis (HP:0000991) | 6.25351482 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.16831529 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.09888497 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.45052491 |
| 9 | Complement deficiency (HP:0004431) | 4.87999300 |
| 10 | Epidermoid cyst (HP:0200040) | 4.80736625 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.51516288 |
| 12 | Joint hemorrhage (HP:0005261) | 4.44686123 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 4.34777794 |
| 14 | Fat malabsorption (HP:0002630) | 4.25715772 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.23137667 |
| 16 | Hyperammonemia (HP:0001987) | 4.18617343 |
| 17 | Hyperglycinemia (HP:0002154) | 4.09477851 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09428897 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.08512127 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.02787116 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.95365116 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.82258827 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82258827 |
| 24 | Ketosis (HP:0001946) | 3.80971471 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.80249091 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79416394 |
| 27 | Hyperglycinuria (HP:0003108) | 3.53721580 |
| 28 | Abnormality of complement system (HP:0005339) | 3.51369239 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.50886793 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46534018 |
| 31 | Steatorrhea (HP:0002570) | 3.38422759 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28642214 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.28610210 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.15080293 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.10732981 |
| 36 | Bifid tongue (HP:0010297) | 3.00202329 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 2.95003580 |
| 38 | * Hyperbilirubinemia (HP:0002904) | 2.94132962 |
| 39 | Cortical dysplasia (HP:0002539) | 2.91545292 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.87225581 |
| 41 | Skin nodule (HP:0200036) | 2.83080697 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.81872763 |
| 43 | Myocardial infarction (HP:0001658) | 2.76518371 |
| 44 | Vascular calcification (HP:0004934) | 2.70515575 |
| 45 | Spontaneous abortion (HP:0005268) | 2.68900561 |
| 46 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.67235030 |
| 47 | Abnormal lung lobation (HP:0002101) | 2.66290217 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.65755111 |
| 49 | Abnormality of the labia minora (HP:0012880) | 2.64821095 |
| 50 | Volvulus (HP:0002580) | 2.58245737 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.56245530 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.55755227 |
| 53 | Cholecystitis (HP:0001082) | 2.55755227 |
| 54 | Ketoacidosis (HP:0001993) | 2.55665658 |
| 55 | Metabolic acidosis (HP:0001942) | 2.55304136 |
| 56 | Absent eyebrow (HP:0002223) | 2.54661617 |
| 57 | Colon cancer (HP:0003003) | 2.49674325 |
| 58 | Lethargy (HP:0001254) | 2.49163785 |
| 59 | Hepatoblastoma (HP:0002884) | 2.46981584 |
| 60 | Mitral stenosis (HP:0001718) | 2.44921819 |
| 61 | Amyloidosis (HP:0011034) | 2.43799570 |
| 62 | Methylmalonic acidemia (HP:0002912) | 2.42798272 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.42192702 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.40947672 |
| 65 | Cerebral edema (HP:0002181) | 2.40799023 |
| 66 | Cholelithiasis (HP:0001081) | 2.40673097 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.40405730 |
| 68 | Papillary thyroid carcinoma (HP:0002895) | 2.36975781 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34403781 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.34403781 |
| 71 | Irritability (HP:0000737) | 2.32933435 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.29001804 |
| 73 | Hypophosphatemic rickets (HP:0004912) | 2.28330323 |
| 74 | * Abnormal gallbladder morphology (HP:0012437) | 2.25949196 |
| 75 | Glomerulonephritis (HP:0000099) | 2.25508608 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.25055409 |
| 77 | Scrotal hypoplasia (HP:0000046) | 2.24961358 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 2.18997126 |
| 79 | Opisthotonus (HP:0002179) | 2.18207386 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.18095812 |
| 81 | Brushfield spots (HP:0001088) | 2.17254208 |
| 82 | Hypoglycemic seizures (HP:0002173) | 2.16945961 |
| 83 | Abnormality of glycolysis (HP:0004366) | 2.16810608 |
| 84 | Increased serum pyruvate (HP:0003542) | 2.16810608 |
| 85 | Spastic paraparesis (HP:0002313) | 2.15882246 |
| 86 | Hypoplastic pelvis (HP:0008839) | 2.14808585 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14645497 |
| 88 | Gonadotropin excess (HP:0000837) | 2.14519578 |
| 89 | Symptomatic seizures (HP:0011145) | 2.14207615 |
| 90 | Enlarged kidneys (HP:0000105) | 2.12593414 |
| 91 | Gingival bleeding (HP:0000225) | 2.09848784 |
| 92 | Genital tract atresia (HP:0001827) | 2.08751117 |
| 93 | Intestinal atresia (HP:0011100) | 2.08263372 |
| 94 | Rickets (HP:0002748) | 2.07831827 |
| 95 | Neoplasm of the adrenal gland (HP:0100631) | 2.05672847 |
| 96 | Malnutrition (HP:0004395) | 2.05451364 |
| 97 | Vaginal atresia (HP:0000148) | 2.02673063 |
| 98 | Spastic diplegia (HP:0001264) | 2.02320696 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.01418654 |
| 100 | Pancreatitis (HP:0001733) | 1.99652917 |
| 101 | Abnormal tarsal ossification (HP:0008369) | 1.98469987 |
| 102 | Vomiting (HP:0002013) | 1.97218126 |
| 103 | Abnormality of chromosome stability (HP:0003220) | 1.95463303 |
| 104 | Parakeratosis (HP:0001036) | 1.93847598 |
| 105 | Short tibia (HP:0005736) | 1.93174103 |
| 106 | Supernumerary spleens (HP:0009799) | 1.92559987 |
| 107 | Thyroid carcinoma (HP:0002890) | 1.91187964 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.91181081 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.91181081 |
| 110 | Menorrhagia (HP:0000132) | 1.90664503 |
| 111 | Embryonal renal neoplasm (HP:0011794) | 1.88876845 |
| 112 | Protuberant abdomen (HP:0001538) | 1.88780712 |
| 113 | Renal hypoplasia (HP:0000089) | 1.88583521 |
| 114 | Neonatal onset (HP:0003623) | 1.88342608 |
| 115 | Meckel diverticulum (HP:0002245) | 1.87055552 |
| 116 | * Abnormality of the gallbladder (HP:0005264) | 1.85964567 |
| 117 | Absent hair (HP:0002298) | 1.85419482 |
| 118 | Abnormality of the duodenum (HP:0002246) | 1.84938053 |
| 119 | Renal cortical cysts (HP:0000803) | 1.84737845 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.84448663 |
| 121 | * Myelomeningocele (HP:0002475) | 1.83760203 |
| 122 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.83587464 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 1.83006074 |
| 124 | Esophageal varix (HP:0002040) | 1.82417790 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.82202738 |
| 126 | Postnatal microcephaly (HP:0005484) | 1.82035727 |
| 127 | Epiphyseal stippling (HP:0010655) | 1.81818827 |
| 128 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.81043331 |
| 129 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.81043331 |
| 130 | Labial hypoplasia (HP:0000066) | 1.80753191 |
| 131 | Abnormality of the ileum (HP:0001549) | 1.80283091 |
| 132 | Generalized aminoaciduria (HP:0002909) | 1.78712885 |
| 133 | Gout (HP:0001997) | 1.78605291 |
| 134 | Alkalosis (HP:0001948) | 1.76601609 |
| 135 | Megaloblastic anemia (HP:0001889) | 1.74501713 |
| 136 | Paraparesis (HP:0002385) | 1.73917994 |
| 137 | Hypoplastic female external genitalia (HP:0012815) | 1.73631865 |
| 138 | Septo-optic dysplasia (HP:0100842) | 1.73524121 |
| 139 | Gait imbalance (HP:0002141) | 1.71463677 |
| 140 | Congenital primary aphakia (HP:0007707) | 1.71348133 |
| 141 | Absent eyelashes (HP:0000561) | 1.71297894 |
| 142 | Thrombophlebitis (HP:0004418) | 1.70979771 |
| 143 | Medial flaring of the eyebrow (HP:0010747) | 1.70681186 |
| 144 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.70343203 |
| 145 | Small intestinal stenosis (HP:0012848) | 1.70071510 |
| 146 | Duodenal stenosis (HP:0100867) | 1.70071510 |
| 147 | Ependymoma (HP:0002888) | 1.68558321 |
| 148 | Type I transferrin isoform profile (HP:0003642) | 1.68345408 |
| 149 | Bile duct proliferation (HP:0001408) | 1.67819172 |
| 150 | Abnormal biliary tract physiology (HP:0012439) | 1.67819172 |
| 151 | Abnormality of urine glucose concentration (HP:0011016) | 1.67735365 |
| 152 | Glycosuria (HP:0003076) | 1.67735365 |
| 153 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.67157988 |
| 154 | Calf muscle hypertrophy (HP:0008981) | 1.65939562 |
| 155 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.65731126 |
| 156 | Abnormality of the calf musculature (HP:0001430) | 1.64754785 |
| 157 | Rhabdomyosarcoma (HP:0002859) | 1.63881851 |
| 158 | Methylmalonic aciduria (HP:0012120) | 1.62836320 |
| 159 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.62578254 |
| 160 | Abnormality of alanine metabolism (HP:0010916) | 1.62578254 |
| 161 | Hyperalaninemia (HP:0003348) | 1.62578254 |
| 162 | Hypothermia (HP:0002045) | 1.62571497 |
| 163 | Poor suck (HP:0002033) | 1.61448140 |
| 164 | Abnormal glycosylation (HP:0012345) | 1.59825105 |
| 165 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.59825105 |
| 166 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59825105 |
| 167 | Abnormal protein glycosylation (HP:0012346) | 1.59825105 |
| 168 | Drooling (HP:0002307) | 1.59425282 |
| 169 | Abolished electroretinogram (ERG) (HP:0000550) | 1.59207884 |
| 170 | Medulloblastoma (HP:0002885) | 1.58904532 |
| 171 | Abnormal hair whorl (HP:0010721) | 1.58870410 |
| 172 | Progressive inability to walk (HP:0002505) | 1.56300235 |
| 173 | Preaxial foot polydactyly (HP:0001841) | 1.55800594 |
| 174 | Micropenis (HP:0000054) | 1.53039622 |
| 175 | Abnormality of vitamin B metabolism (HP:0004340) | 1.52741204 |
| 176 | Bifid scrotum (HP:0000048) | 1.52380410 |
| 177 | Glioma (HP:0009733) | 1.52124838 |
| 178 | Clitoromegaly (HP:0000057) | 1.50603197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.39750019 |
| 2 | SIK1 | 4.08732870 |
| 3 | FGFR4 | 3.55084214 |
| 4 | ERBB4 | 3.34525665 |
| 5 | TRIM28 | 2.84499133 |
| 6 | TSSK6 | 2.79944990 |
| 7 | PBK | 2.71402120 |
| 8 | STK39 | 2.70951293 |
| 9 | MKNK2 | 2.64425536 |
| 10 | EPHB1 | 2.61076096 |
| 11 | WNK3 | 2.44178193 |
| 12 | ERN1 | 2.37356242 |
| 13 | PLK4 | 2.35321074 |
| 14 | INSRR | 2.34356350 |
| 15 | MST4 | 2.33877160 |
| 16 | SRPK1 | 2.27492784 |
| 17 | FGFR2 | 2.26659112 |
| 18 | MST1R | 2.23703624 |
| 19 | BMPR1B | 2.19131639 |
| 20 | MET | 2.12097899 |
| 21 | TAOK3 | 2.09550738 |
| 22 | OBSCN | 2.07200706 |
| 23 | TTK | 2.05534035 |
| 24 | PNCK | 2.03798784 |
| 25 | EIF2AK3 | 2.02774699 |
| 26 | WEE1 | 2.02282486 |
| 27 | MKNK1 | 2.01244298 |
| 28 | NEK1 | 2.01185569 |
| 29 | PLK3 | 1.99726816 |
| 30 | OXSR1 | 1.85323404 |
| 31 | MAP3K14 | 1.82954397 |
| 32 | ACVR1B | 1.81806625 |
| 33 | PKN1 | 1.75662846 |
| 34 | PKN2 | 1.72454381 |
| 35 | ERBB3 | 1.72319775 |
| 36 | BUB1 | 1.67952023 |
| 37 | MAP2K4 | 1.62751708 |
| 38 | MAP3K4 | 1.59510711 |
| 39 | BCR | 1.52258178 |
| 40 | PIK3CG | 1.50684696 |
| 41 | ABL2 | 1.49004295 |
| 42 | PLK2 | 1.44797683 |
| 43 | AKT3 | 1.36395344 |
| 44 | EIF2AK1 | 1.32814049 |
| 45 | CSNK1G3 | 1.30417960 |
| 46 | BRSK2 | 1.27908116 |
| 47 | NEK9 | 1.26196102 |
| 48 | CSNK1G1 | 1.26050804 |
| 49 | ZAK | 1.23664633 |
| 50 | SGK223 | 1.20067170 |
| 51 | SGK494 | 1.20067170 |
| 52 | FRK | 1.19480869 |
| 53 | LATS1 | 1.17128643 |
| 54 | CSNK1A1L | 1.14091282 |
| 55 | DAPK2 | 1.13748936 |
| 56 | CSNK1G2 | 1.10440610 |
| 57 | TYK2 | 1.10178464 |
| 58 | CDC7 | 1.09546227 |
| 59 | MAPK11 | 1.09478263 |
| 60 | FGFR1 | 1.09052427 |
| 61 | PRKCQ | 1.08497782 |
| 62 | TAF1 | 1.03814735 |
| 63 | MAP4K2 | 1.01213382 |
| 64 | PLK1 | 1.01053688 |
| 65 | CAMK2G | 1.00907004 |
| 66 | FER | 0.98042506 |
| 67 | PRKAA2 | 0.95641351 |
| 68 | STK38L | 0.94299831 |
| 69 | CASK | 0.90930311 |
| 70 | MAPK15 | 0.90871161 |
| 71 | MAPK4 | 0.88008853 |
| 72 | STK3 | 0.84226308 |
| 73 | PINK1 | 0.84170382 |
| 74 | MAP3K12 | 0.84040038 |
| 75 | GSK3A | 0.83973428 |
| 76 | STK16 | 0.82967954 |
| 77 | EPHA3 | 0.82747961 |
| 78 | JAK2 | 0.82233858 |
| 79 | MAPK13 | 0.82027514 |
| 80 | IRAK2 | 0.82001909 |
| 81 | PIK3CA | 0.80952208 |
| 82 | VRK1 | 0.80844333 |
| 83 | EIF2AK2 | 0.79837069 |
| 84 | PRPF4B | 0.78898241 |
| 85 | PRKCZ | 0.78495869 |
| 86 | MAP3K3 | 0.77827714 |
| 87 | MAP3K7 | 0.77641948 |
| 88 | TBK1 | 0.77126035 |
| 89 | JAK1 | 0.77071678 |
| 90 | ERBB2 | 0.76730038 |
| 91 | CSK | 0.76111643 |
| 92 | LIMK1 | 0.75112751 |
| 93 | PAK3 | 0.74232038 |
| 94 | PRKACG | 0.74184859 |
| 95 | MAP2K7 | 0.72854502 |
| 96 | FLT3 | 0.72703827 |
| 97 | MAP3K13 | 0.71965862 |
| 98 | PTK6 | 0.70536081 |
| 99 | NTRK1 | 0.70432270 |
| 100 | TESK2 | 0.69010544 |
| 101 | EPHA4 | 0.68007049 |
| 102 | MINK1 | 0.67742354 |
| 103 | WNK4 | 0.65596207 |
| 104 | MAPK12 | 0.64520760 |
| 105 | CAMK1D | 0.62442594 |
| 106 | MARK1 | 0.62336668 |
| 107 | MAPKAPK5 | 0.61827505 |
| 108 | CAMK1G | 0.61357449 |
| 109 | MAPK7 | 0.61266420 |
| 110 | YES1 | 0.59310442 |
| 111 | ATM | 0.58842072 |
| 112 | PDPK1 | 0.58351369 |
| 113 | TGFBR1 | 0.58226762 |
| 114 | IKBKE | 0.57929520 |
| 115 | TIE1 | 0.57763323 |
| 116 | KDR | 0.56423745 |
| 117 | TNIK | 0.54897570 |
| 118 | BRD4 | 0.54872517 |
| 119 | LATS2 | 0.54163498 |
| 120 | DMPK | 0.54061118 |
| 121 | DYRK3 | 0.53819812 |
| 122 | IRAK1 | 0.53712858 |
| 123 | IGF1R | 0.53602240 |
| 124 | FGR | 0.53128932 |
| 125 | PASK | 0.53035322 |
| 126 | CCNB1 | 0.51824624 |
| 127 | CSNK1E | 0.51341073 |
| 128 | CSF1R | 0.49952997 |
| 129 | CAMK2B | 0.47906549 |
| 130 | IRAK3 | 0.47556652 |
| 131 | DYRK2 | 0.47394900 |
| 132 | ITK | 0.47144144 |
| 133 | SGK2 | 0.47089705 |
| 134 | PTK2 | 0.46150770 |
| 135 | NEK6 | 0.45999972 |
| 136 | PRKCG | 0.44235578 |
| 137 | NEK2 | 0.43362486 |
| 138 | GRK1 | 0.43339891 |
| 139 | MAP2K1 | 0.43332531 |
| 140 | MAP3K2 | 0.42414031 |
| 141 | SGK3 | 0.42199220 |
| 142 | ADRBK2 | 0.41375892 |
| 143 | RPS6KA4 | 0.41349364 |
| 144 | PRKCH | 0.39478168 |
| 145 | BRAF | 0.39217539 |
| 146 | CAMK2A | 0.38875821 |
| 147 | NLK | 0.38270239 |
| 148 | SIK3 | 0.37742091 |
| 149 | ABL1 | 0.37400548 |
| 150 | PRKCA | 0.36914420 |
| 151 | PRKAA1 | 0.36483396 |
| 152 | CHEK2 | 0.35947254 |
| 153 | NUAK1 | 0.35856418 |
| 154 | ATR | 0.34586006 |
| 155 | GRK6 | 0.34433077 |
| 156 | UHMK1 | 0.34189406 |
| 157 | PRKDC | 0.34107704 |
| 158 | PRKG1 | 0.34093577 |
| 159 | CAMK2D | 0.33989459 |
| 160 | PRKCE | 0.33722274 |
| 161 | EGFR | 0.33564277 |
| 162 | CSNK1A1 | 0.32414821 |
| 163 | PRKACA | 0.31593076 |
| 164 | NTRK3 | 0.31373180 |
| 165 | BRSK1 | 0.31153069 |
| 166 | PRKACB | 0.31111256 |
| 167 | CDK3 | 0.30163976 |
| 168 | CHEK1 | 0.29760433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.22847627 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47179950 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14743454 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.14671025 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86406573 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.70110212 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51291781 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51074837 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48975170 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42340700 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39097146 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35302224 |
| 13 | * Steroid biosynthesis_Homo sapiens_hsa00100 | 2.32889399 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29236964 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.27273004 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18452788 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.11984992 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11707251 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06248786 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.06248468 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99217388 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97680666 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97096512 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94537258 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93784401 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81336786 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74565783 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.71884341 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70995609 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69703625 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65368498 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.65016935 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64499561 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62447457 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59050232 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51003786 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49645968 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48016093 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.46854280 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40911864 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38740823 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38566092 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.36780842 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29768956 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20248408 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18820718 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16491460 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.16429867 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13176942 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 1.11787367 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.10922479 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09746655 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08144070 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02199353 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02057321 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02051405 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98530401 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97851571 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97371223 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 0.97023350 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90655606 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 0.88102897 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87208708 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80859233 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 0.80200939 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79597106 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79386535 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78445434 |
| 69 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.74580543 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74466905 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73824375 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68006020 |
| 73 | Cell cycle_Homo sapiens_hsa04110 | 0.67522647 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66969697 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64485193 |
| 76 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61258188 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61212198 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.58137331 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57161507 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.56354549 |
| 81 | Nicotine addiction_Homo sapiens_hsa05033 | 0.56225573 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.53965661 |
| 83 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.52283515 |
| 84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50289339 |
| 85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50223001 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49174999 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48674195 |
| 88 | Spliceosome_Homo sapiens_hsa03040 | 0.47808206 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46977436 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46431796 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44803563 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43827811 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42957437 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40735044 |
| 95 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38394855 |
| 96 | DNA replication_Homo sapiens_hsa03030 | 0.38389953 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.38138455 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37917564 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35902560 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.33193775 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31161434 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30204730 |
| 103 | Purine metabolism_Homo sapiens_hsa00230 | 0.30186026 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27580848 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.24482517 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24226020 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16322488 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11896495 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11866803 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10469816 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.07143421 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05976533 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.03197050 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02794784 |
| 115 | Pertussis_Homo sapiens_hsa05133 | -0.2249792 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2239717 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2224804 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | -0.2188475 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2054286 |
| 120 | Phagosome_Homo sapiens_hsa04145 | -0.1882826 |
| 121 | Lysosome_Homo sapiens_hsa04142 | -0.1688249 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1573756 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | -0.1513576 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1357484 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1256503 |
| 126 | Malaria_Homo sapiens_hsa05144 | -0.1178845 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1123408 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1037518 |
| 129 | Protein export_Homo sapiens_hsa03060 | -0.0972638 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0846078 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0688241 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0572929 |

